Clearance Summary
BTI BIOX III OXIMETER CRITICAL CAREUNI received FDA 510(k) clearance under submission number K833826, sponsored by Biox Technology, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 1983-12-30.
- Submission: K833826
- Applicant / Sponsor: Biox Technology, Inc.
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.2700
- Decision date: 1983-12-30
Classification & Regulation
This clearance is catalogued under FDA product code DQA and 21 CFR 870.2700, within the Cardiovascular review panel as a Class II device.